Hypoxic pulmonary vasoconstriction in isolated blood-perfused rat lung; modulation by thromboxane A2, platelet-activating factor, cysteinly leukotrienes and endothelin-1

Polish Journal of Pharmacology

Volumn 54, Issue 5, 2002, Pages 433-441

  Chłopucki, Stefan ^a   Bartuś, Joanna B ^a   Gryglewski, Ryszard J ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Endothelin; Hypoxia; Leukotrienes; Nitric oxide; PAF; Pulmonary vasoconstriction; Thromboxane

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; BEPAFANT; CAMONAGREL; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; LIPOXYGENASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PEPTIDOLEUKOTRIENE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOXANE A2; THROMBOXANE SYNTHASE INHIBITOR; 5-LIPOXYGENASE-ACTIVATING PROTEIN; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CARRIER PROTEIN; CELL SURFACE RECEPTOR; ENDOTHELIN A RECEPTOR; ENDOTHELIN RECEPTOR; FIBRINOGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; LEUKOTRIENE; MEMBRANE PROTEIN; NITRIC OXIDE SYNTHASE; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; THROMBOXANE SYNTHASE;

ANIMAL MODEL; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG SELECTIVITY; HYPOXIA; ISOLATED LUNG; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; LUNG PERFUSION; LUNG VASOCONSTRICTION; LUNG VENTILATION; LUNG WEIGHT; MEDIATOR; NONHUMAN; RAT; STATISTICAL ANALYSIS; TIDAL VOLUME; VENOUS PRESSURE; ANIMAL; ANOXIA; COMPARATIVE STUDY; DRUG ANTAGONISM; IN VITRO STUDY; LUNG; METABOLISM; PATHOPHYSIOLOGY; PERFUSION; PULMONARY ARTERY; VASOCONSTRICTION; WISTAR RAT;

ANIMALS; ANOXIA; CARRIER PROTEINS; ENDOTHELIN-1; LEUKOTRIENES; LUNG; MEMBRANE PROTEINS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PERFUSION; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PULMONARY ARTERY; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTORS, CELL SURFACE; RECEPTORS, ENDOTHELIN; RECEPTORS, G-PROTEIN-COUPLED; THROMBOXANE A2; THROMBOXANE-A SYNTHASE; VASOCONSTRICTION;

EID: 1842842460     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Ahmed T., Oliver W. Jr., Wanner A.: Variability of hypoxic pulmonary vasoconstriction in sheep. Role of prostaglandins. Amer. Rev. Respir. Dis., 1983, 127, 59-62.
2. Archer S., Tolins J., Raij L., Weir E.: Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium-derived relaxing factor. Biochem. Biophys. Res. Commun., 1989, 164, 1198-205.
3. Avontuur J., Boomsma F., van den Meiracker A., de Jong F., Bruining H.: Endothelin-1 and blood pressure after inhibition of nitric oxide synthesis in human septic shock. Circulation, 1999, 99, 271-275.
4. Bartus J., Chlopicki S., Gryglewski R.: Increased pneumotoxicity of lipopolysaccharide from E. coli in nitric oxide deficient blood-perfused rat lungs. J. Physiol. Pharmacol., 1997, 48, 655-663.
5. Bennie R., Packer C., Powell D., Jin N., Rhoades R.: Biphasic contractile response of pulmonary artery to hypoxia. Amer. J. Physiol., 1991, 261, 156-163.
6. Chen S.J., Chen Y.F., Opgenorth T.J., Wessale J.L., Meng Q.C., Durand J., DiCarlo V.S., Oparil S.: The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats. J. Cardiovasc. Pharmacol., 1997, 29, 713-725.
7. Chlopicki S., Bartus J., Gryglewski R.: Biphasic response to lipopolysaccharide from E. coli in the isolated ventilated blood-perfused rat lung. J. Physiol. Pharmacol., 1999, 50, 551-565.
8. Chlopicki S., Bartus J., Walski M., Wolkow P., Gryglewski R.: Nitric oxide - a safeguard of pulmonary microcirculation in early endotoxaemia. IOS Press., 2001, 137-148.
9. Coppock E., Martens J., Tamkun M.: Molecular basis of hypoxia-induced pulmonary vasoconstriction: role of voltage-gated K+ channels. Amer. J. Physiol.-Lung Cell. M.Ph., 2001, 281, 1-12.
10. Demiryurek A., Wadsworth R., Kane K., Peacock A.: The role of endothelium in hypoxic constriction of human pulmonary artery rings. Amer. Rev. Respir. Dis., 1993, 147, 283-290.
11. DeWitt B.J., Champion H.C., Marrone J. R., McNamara D.B., Giles T.D., Greenberg S.S., Kadowitz P.J.: Differential effects of L-N5-(1-iminoethyl)-ornithine on tone and endothelium-dependent vasodilator responses. Amer. J. Physiol., 1997, 273, 588-594.
12. Farber H., Barnett H.: Differences in prostaglandin metabolism in cultured aortic and pulmonary arterial endothelial cells exposed to acute and chronic hypoxia. Circ. Res., 1991, 68, 1446-1457.
13. Feinmark S., Cannon P.: Endothelial cell leukotriene C4 synthesis results from intercellular transfer of leukotriene A4 synthesized by polymorphonuclear leukocytes. J. Biol. Chem., 1986, 261, 16466-16472.
14. ω-nitro-L-arginine methyl ester, LY83583, glybenclamide and L158809 on pulmonary circulation. Eur. J. Pharmacol., 1994, 263, 133-40.
15. Gaine S., Hales M., Flavahan N.: Hypoxic pulmonary endothelial cells release a diffusible contractile factor distinct from endothelin. Amer. J. Physiol., 1998, 274, L657-L664.
16. Gorsky B., Lloyd T. Jr.: Effects of perfusate composition on hypoxic vasoconstriction in isolated lung lobes. J. Appl. Physiol., 1967, 23, 683-686.
17. Hakim T., Malik A.: Hypoxic vasoconstriction in blood and plasma perfused lungs. Respir. Physiol., 1988, 72, 109-121.
18. Holm P.: Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction. Scand. Cardiovasc. J. Suppl., 1997, 46, 1-40.
19. Hoshino Y., Morrison K., Vanhoutte P.: Mechanisms of hypoxic vasoconstriction in the canine isolated pulmonary artery: role of endothelium and sodium pump. Amer. J. Physiol., 1994, 267, 120-127.
20. Jin N., Packer C., Rhoades R.: Pulmonary arterial hypoxic contraction: signal transduction. Amer. J. Physiol., 1992, 263, 73-78.
21. Kempfert C., Brandt R., Siewert B., Kanowski U., Oddoy A.: Effects of the PAF antagonist WEB 2086 on hypoxia and angiotensin II-induced pulmonary vasoconstriction in the isolated perfused rat lung. Pneumologie, 1991, 45, 799-803.
22. Leach R., Robertson T., Twort C., Ward J.: Hypoxic vasoconstriction in rat pulmonary and mesenteric arteries. Amer. J. Physiol., 1994, 266, 223-231.
23. Leach R., Twort C., Cameron I., Ward J.: The mechanism of action of endothelin-1 on small pulmonary arterial vessels. Pulm. Pharmacol., 1990, 3, 103-109.
24. Lewis R., Austen K., Soberman R.: Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med., 1990, 323, 645-655.
25. Liu S., Crawley D., Barnes P., Evans T.: Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Amer. Rev. Respir. Dis., 1991, 143, 32-37.
26. Manohar M., Goetz T.: L-NAME does not affect exercise-induced pulmonary hypertension in thoroughbred horses. J. Appl. Physiol., 1998, 84, 1902-1908.
27. McCormack D., Barnes P., Evans T.: Evidence against a role for platelet-activating factor in hypoxic pulmonary vasoconstriction in the rat. Clin. Sci., 1989, 77, 439-443.
28. McCormack D., Barnes P., Evans T.: Platelet-activating factor: evidence against a role in hypoxic pulmonary vasoconstriction. Crit. Care Med., 1990, 18, 1398-1402.
29. Morganroth M., Reeves J., Murphy R., Voelkel N.: Leukotriene synthesis and receptor blockers block hypoxic pulmonary vasoconstriction. J. Appl. Physiol., 1984, 56, 1340-1346.
30. Ogawa Y., Kawabe J., Onodera S., Tobise K., Marita K., Harada T., Hirayama T., Takeda A..: Role of endothelium in biphasic hypoxic response of the isolated pulmonary artery in the rat. Jpn. Circ. J., 1993, 57, 228-236.
31. Oparil S., Chen S.J., Meng Q.C., Elton TS., Yano M., Chen Y.F.: Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat. Amer. J. Physiol., 1995, 268, 95-100.
32. Pape D., Goineau S., Guillo P., Durand-Castel X., Bellissant E.: Endothelin, but not angiotensin II, contributes to the hypoxic contractile response of large isolated pulmonary arteries in the rat. Fundam. Clin. Pharmacol., 1999, 13, 461-467.
33. Prevost M., Cariven C., Simon M., Chap H., Douste-Blazy L.: Platelet activating factor (PAF-acether) is released into rat pulmonary alveolar fluid as a consequence of hypoxia. Biochem. Biophys. Res. Commun., 1984, 119, 58-63.
34. Russell P., Wright C., Kapeller K., Barer G., Howard P.: Attenuation of chronic hypoxic pulmonary hypertension in rats by cyclooxygenase products and by nitric oxide. Eur. Resp. J., 1993, 6, 1501-1506.
35. Sato K., Morio Y., Morris K., Rodman D., McMurtry I.: Mechanism of hypoxic pulmonary vasoconstriction involves ET(A) receptor-mediated inhibition of K(ATP) channel. Amer. J. Physiol.-Lung Cell. M.Ph., 2000, 278, 434-442.
36. Shaul P., Kinane B., Farrar M., Buja L., Magness R.: Prostacyclin production and mediation of adenylate cyclase activity in the pulmonary artery. Alterations after prolonged hypoxia in the rat. J. Clin. Invest., 1991, 88, 447-455.
37. Sprague R., Thiemermann C., Vane J.: Endogenous endothelium-derived relaxing factor opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in anesthetized rabbits. Proc. Nat. Acad. Sci. USA, 1992, 89, 8711-8715.
38. Takeoka M., Ishizaki T., Sakai A., Chang S.W., Shigemori K., Higashi T., Ueda G.: Effect of BQ123 on vasoconstriction as a result of either hypoxia or endothelin-1 in perfused rat lungs. Acta Physiol. Scand., 1995, 155, 53-60.
39. Turner J., Kozlowski R.: Relationship between membrane potential, delayed rectifier K+ currents and hypoxia in rat pulmonary arterial myocytes. Exp. Physiol., 1997, 82, 629-645.
40. Uhlig S., Heiny O.: Measuring the weight of the isolated perfused rat lung during negative pressure ventilation. J. Pharmacol. Toxicol. Meth., 1995, 33, 147-152.
41. Uhlig S., Nusing R., von Bethmann A., Featherstone R.L., Klein T., Brasch F., Muller K.M., Ulrich V, Wendel A.: Cyclooxygenase-2-dependent bronchoconstriction in perfused rat lungs exposed to endotoxin. Mol. Med., 1996, 2, 373-383.
42. Uhlig S., Wollin L.: An improved setup for the isolated perfused rat lung. J. Pharmacol. Toxicol. Meth., 1994, 31, 85-94.
43. Uhlig S., Wollin L., Wendel A.: Contributions of thromboxane and leukotrienes to PAF-induced impairment of lung function in the rat. J. Appl. Physiol., 1994, 77, 262-269.
44. van Gelderen E., Den Boer M., Saxena P.: NG-nitro-L-arginine methyl ester: systemic and pulmonary haemodynamics, tissue blood flow and arteriovenous shunting in the pig. Naunyn-Schmied. Arch. Pharmacol., 1993, 348, 417-423.
45. Voelkel N.: Mechanisms of hypoxic pulmonary vasoconstriction. Amer. Rev. Respir. Dis., 1986, 133, 1186-1195.
46. Voelkel N.F., Tuder R.M., Wade K., Hoper M., Lepley R.A., Goulet J.L., Koller B.H., Fitzpatrick F.: Inhibition of 5-lipooxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats. J. Clin. Invest., 1996, 97, 2491-2498.
47. von Euler U.S., Liljestrand G.: Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol. Scand., 1946, 12, 30.
48. Ward J., Robertson T.: The role of the endothelium in hypoxic pulmonary vasoconstriction. Exp. Physiol., 1995, 80, 793-801.
49. Weitzenblum E., Hirth C., Ducolone A., Mirhom R., Rasaholinjanahary J., Ehrhart M.: Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax, 1981, 36, 752-758.